This year’s ISPE Germany/Austria/Switzerland (D/A/CH) Affiliate workshop, “Pharma’s Journey to Digital Manufacturing and Supply,” united pharma leaders, technology experts and regulatory agencies for three days of intense exchanges on the digital transformation of our industry. Its innovative, highly interactive format enabled all 130 participants to engage, contribute, and learn from each...

A Message from the President and CEO, ISPE, on the 2025 ISPE Boston Product Show

Engineers know that data is only as valuable as the decisions it drives. The Data-Driven Manufacturing Excellence Solutions track at the 2025 ISPE Pharma 4.0™ Conference will showcase how pharma organizations...

The 2025 ISPE Annual Meeting & Expo, ISPE’s largest event of the year, is quickly approaching, taking place 26–29 October in Charlotte, North Carolina, USA and virtually. In the videos and transcripts...

Bayer, a global leader in the pharmaceutical industry, is committed to advancing healthcare through innovative solutions. With their new Cell Therapy Launch and Manufacturing Facility, Bayer aims to provide hope to patients with unmet medical needs by finding a cure and making life-changing therapies more accessible to all. The facility signifies a major advancement in the production and...

Artificial Intelligence isn’t just theory anymore—it’s revolutionizing pharmaceutical operations today. At this year’s 2025 ISPE Pharma 4.0™ Conference, the AI Case Studies: Benefits and Challenges track...

North Carolina has rapidly emerged as one of the nation’s leading hubs for pharmaceutical manufacturing, with a thriving ecosystem that brings together global companies, innovative startups, world-class research institutions, and a highly skilled workforce. Attending the

Ciby Abraham, PhD, Senior Director and Group Manager, Project and Product Leadership, AstraZeneca, is Committee Chair for the 2025 ISPE Annual Meeting & Expo, ISPE’s largest event of the year. The event will take place 26–29 October in Charlotte, North Carolina, USA.

Sanofi Toronto manufactures and distributes up to 100 million pediatric and adult vaccines for infectious diseases such as diphtheria, pertussis, tetanus each year. The Toronto site has been in continuous operation since 1914 and consists of more than 30 buildings across a 52-acre site. Sanofi is a leading research and development company and the largest vaccine producer in Canada, protecting...

The pharmaceutical industry is evolving—fast. As patients’ needs grow more complex and technologies become more advanced, the demand for innovative, patient-centric drug delivery solutions is reshaping how we think about manufacturing. This October, the

ISPE Podcast: Shaping the Future of Pharma has published an episode featuring Gunter Baumgartner, Senior Vice President, Head of Global Engineering at Takeda Pharmaceuticals International AG and...

Johnson & Johnson Innovative Medicine, part of the Johnson & Johnson family of companies, develops innovative and integrated products and medicines to restore and extend the quality of life for patients globally. The expansion of Johnson & Johnson’s BioCork facility in Ringaskiddy, Cork, Ireland increased the existing biomanufacturing capacity at the plant while also creating...

From guidance on how to define temperature and humidity requirements and cleanroom design in pharmaceutical and biotechnology facilities to chemistry, manufacturing, and controls (CMC) requirements for new drugs in Latin America and evolving regulatory requirements in China, the top read

You won't want to miss the 2025 ISPE Annual Meeting & Expo in Charlotte, North Carolina, USA 26–29 October. This isn’t just another industry gathering; it’s where our community challenges assumptions, learns from each other, and shapes the future...

Johnson & Johnson’s facility in Latina, Italy, is a small molecule manufacturing site for global launches and commercial supply of solid dosage forms. It is also the strategic launch and growth site for manufacturing and packaging of solids products. Johnson & Johnson Latina site’s diverse portfolio includes multiple therapeutic areas.

Allyssa Wilcox is a Sourcing Manager for Site Operations Procurement at AstraZeneca. She is an ISPE member and is also a member of the ISPE Chesapeake Bay Area Chapter and ISPE’s Women in Pharma®. In this interview, Wilcox delves into her ISPE membership experience, volunteer activities with ISPE, sources of inspiration, what trend excites her most in the industry, and more.